Page last updated: 2024-08-22

trolamine salicylate and Cardiac Conduction Defect

trolamine salicylate has been researched along with Cardiac Conduction Defect in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Britsemmer, L; Dekker, J; Heslinga, SC; Lems, WF; Nurmohamed, MT; Turk, SA; van der Lugt, V; van Schaardenburg, D1
SIGG, K1

Other Studies

2 other study(ies) available for trolamine salicylate and Cardiac Conduction Defect

ArticleYear
The Relationship Between Cardiac Conduction Times, Cardiovascular Risk Factors, and Inflammation in Patients with Early Arthritis.
    The Journal of rheumatology, 2017, Volume: 44, Issue:5

    Topics: Adult; Aged; Arthritis; Cardiac Conduction System Disease; Cardiovascular Diseases; Comorbidity; Female; Heart Conduction System; Heart Rate; Humans; Inflammation; Male; Middle Aged; Prevalence; Risk Factors

2017
[Therapeutic anesthesia with panthesin in asthma. angina pectoris, cardiac arrhythmia, polyarthritis, &c].
    Schweizerische medizinische Wochenschrift, 1951, Jan-06, Volume: 81, Issue:1

    Topics: Anesthesia; Angina Pectoris; Arrhythmias, Cardiac; Arthritis; Asthma; Brugada Syndrome; Cardiac Conduction System Disease; Heart Conduction System; Humans; Leucine; para-Aminobenzoates

1951